Beta Bionics Secures $100M In Series D Funding To Expand Artificial Pancreas Tech

After receiving US FDA clearance in May, Beta Bionics secured $100m in financing which is expected to be used to commercialize its iLet Bionic Pancreas and “further develop and test the bi-hormonal bionic pancreas.”